A 58-year-old male patient with chronic kidney disease (eGFR 25 mL/min) is undergoing elective hip arthroplasty. Induction is uneventful with propofol and fentanyl. For muscle relaxation during the 3-hour procedure, which agent would require the LEAST dose adjustment or monitoring for prolonged blockade?

Explanation

## Muscle Relaxant Selection in Renal Impairment **Key Point:** In patients with severe renal dysfunction, **Hofmann elimination-dependent agents** (atracurium, cisatracurium) are preferred because they do not rely on renal or hepatic clearance and maintain predictable pharmacokinetics. ### Metabolism and Clearance of Neuromuscular Blockers | Agent | Metabolism | Renal Dependence | Use in CKD | Duration | |-------|-----------|------------------|-----------|----------| | **Cisatracurium** | **Hofmann elimination + ester hydrolysis** | **Minimal** | **Preferred** | 40–60 min | | **Atracurium** | Hofmann elimination + ester hydrolysis | Minimal | Preferred | 30–45 min | | **Vecuronium** | Hepatic (80%) + renal (20%) | **Moderate–High** | Requires dose adjustment | Prolonged | | **Pancuronium** | Hepatic (10–40%) + renal (60–90%) | **Very High** | Avoid or reduce dose | Markedly prolonged | | **Mivacurium** | Plasma cholinesterase | Minimal | Safe but unpredictable if pseudocholinesterase deficiency | 12–20 min | **High-Yield:** Cisatracurium is the **gold standard** for patients with renal impairment because: 1. Hofmann elimination occurs spontaneously at physiologic pH and temperature (organ-independent) 2. Ester hydrolysis by non-specific plasma esterases (not liver or kidney) 3. Dose does NOT need adjustment in CKD 4. Duration remains predictable even with repeated dosing ### Mechanism of Hofmann Elimination Hofmann elimination is a **temperature- and pH-dependent degradation** that occurs spontaneously in the bloodstream: - **Temperature-dependent:** Occurs at body temperature (37°C) - **pH-dependent:** Optimal at physiologic pH (7.4) - **Organ-independent:** No hepatic or renal metabolism required - **Predictable:** Duration remains constant regardless of organ function **Clinical Pearl:** Cisatracurium is the preferred agent for: - Severe renal impairment (eGFR < 30) - Hepatic dysfunction - Elderly patients with multiple organ dysfunction - Prolonged surgeries where repeated dosing is needed ### Why Other Options Are Problematic in CKD **Vecuronium:** 80% hepatic + 20% renal metabolism → prolonged duration and accumulation in CKD; requires dose reduction and extended monitoring intervals. **Pancuronium:** 60–90% renal excretion → severely prolonged blockade in CKD; can accumulate with repeated dosing; risk of prolonged paralysis and ICU stay. **Mivacurium:** While Hofmann elimination-independent, it is hydrolyzed by plasma cholinesterase; if patient has pseudocholinesterase deficiency (genetic or acquired in CKD/malnutrition), duration becomes unpredictable and dangerously prolonged.